Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans

Infection and Immunity

Volumn 74, Issue 9, 2006, Pages 5284-5291

  De Haar, Susanne F ^a   Hiemstra, Pieter S ^b   Van Steenbergen, Martijn T J M ^a   Everts, Vincent ^a   Beertsen, Wouter ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHEPSIN G; DIPEPTIDYL PEPTIDASE I; ELASTASE; HUMAN CATIONIC ANTIMICROBIAL PROTEIN 18; LEUKOTOXIN; MYELOBLASTIN; POLYPEPTIDE ANTIBIOTIC AGENT; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CELL DAMAGE; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVITY; GENE MUTATION; HOST RESISTANCE; HUMAN; HUMAN CELL; KERATOSIS PALMOPLANTARIS; NEUTROPHIL; PERIODONTITIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; WESTERN BLOTTING;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOBACILLUS INFECTIONS; ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; EXOTOXINS; FEMALE; HUMANS; MALE; NEUTROPHILS; PAPILLON-LEFEVRE DISEASE; SERINE ENDOPEPTIDASES;

EID: 33748042966     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.02016-05     Document Type: Article

References (78)

1. Al Khenaizan, S. 2002. Papillon-Lefevre syndrome: the response to acitretin. Int. J. Dermatol. 41:938-941.
2. Almuneef, M., S. Al Khenaizan, S. Al Ajaji, and A. Al Anazi. 2003. Pyogenic liver abscess and Papillon-Lefevre syndrome: not a rare association. Pediatrics 111:e85-e88.
3. Bangalore, N., J. Travis, V. C. Onunka, J. Pohl, and W. M. Shafer. 1990. Identification of the primary antimicrobial domains in human neutrophil cathepsin G. J. Biol. Chem. 265:13584-13588.
4. Belaaouaj, A., R. McCarthy, M. Baumann, Z. Gao, T. J. Ley, S. N. Abraham, and S. D. Shapiro. 1998. Mice lacking neutrophil elastase reveal impaired host defense against gram-negative bacterial sepsis. Nat. Med. 4:615-618.
5. Bimstein, E., J. Lustmann, M. N. Sela, Z. B. Neriah, and W. A. Soskolne. 1990. Periodontitis associated with Papillon-Lefevre syndrome. J. Periodontol. 61:373-377.
6. Borroni, G., A. Pagani, A. Carcaterra, R. Pericoli, P. Gabba, and M. Marconi. 1985. Immunological alterations in a case of Papillon-Lefevre syndrome with recurrent cutaneous infections. Dermatologica 170:27-30.
7. Boutsi, E. A., M. Umeda, T. Nagasawa, N. Laosrisin, and I. Ishikawa. 1997. Follow-up of two cases of Papillon-Lefevre syndrome and presentation of two new cases. Int. J. Periodontics Restorative Dent. 17:334-347.
8. Brogan, J. M., E. T. Lally, K. Poulsen, M. Kilian, and D. R. Demuth. 1994. Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains. Infect. Immun. 62:501-508.
9. Brown, R. S., G. L. Hays, C. M. Flaitz, P. A. O'Neill, K. Abramovitch, and R. R. White. 1993. A possible late onset variation of Papillon-Lefevre syndrome: report of 3 cases. J. Periodontol. 64:379-386.
10. Bullon, P., A. Pascual, M. C. Fernandez-Novoa, M. V. Borobio, M. A. Muniain, and F. Camacho. 1993. Late onset Papillon-Lefevre syndrome? A chromosomic, neutrophil function and microbiological study. J. Clin. Periodontol. 20:662-667.
11. Campbell, E. J., E. K. Silverman, and M. A. Campbell. 1989. Elastase and cathepsin-G of human monocytes: quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol. 143:2961-2968.
12. Claesson, R., E. Johansson, and J. Carlsson. 1994. Oxygen-dependent modulation of release and activity of polymorphonuclear leukocyte granule products. Oral Microbiol. Immunol. 9:81-87.
13. Clerehugh, V., D. B. Drucker, G. J. Seymour, and P. S. Bird. 1996. Microbiological and serological investigations of oral lesions in Papillon-Lefevre syndrome. J. Clin. Pathol. 49:255-257.
14. Cole, A. M., J. Shi, A. Ceccarelli, Y. H. Kim, A. Park, and T. Ganz. 2001. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 97:297-304.
15. Daniel, M. A., and T. E. Van Dyke. 1996. Alterations in phagocyte function and periodontal infection. J. Periodontol. 67:1070-1075.
16. de Haar, S. F., D. C. Jansen, T. Schoenmaker, H. De Vree, V. Everts, and W. Beertsen. 2004. Loss-of-function mutations in cathepsin C in two families with Papillon-Lefevre syndrome are associated with deficiency of serine proteinases in PMNs. Mutat. Brief 714:1-7. [Online.] http://www3.interscience .wiley.com/homepages/38515/pdf/mutation/714.pdf.
17. De Vree, H., K. Steenackers, and J. A. De Boever. 2000. Periodontal treatment of rapid progressive periodontitis in 2 siblings with Papillon-Lefevre syndrome: 15-year follow-up. J. Clin. Periodontol. 27:354-360.
18. Ebersole, J. L., D. Cappelli, and S. C. Holt. 2001. Periodontal diseases: to protect or not to protect is the question? Acta Odontol. Scand. 59:161-166.
19. Ebersole, J. L., L. Kesavalu, S. L. Schneider, R. L. Machen, and S. C. Holt. 1995. Comparative virulence of periodontopathogens in a mouse abscess model. Oral Dis. 1:115-128.
20. Eickholz, P., B. Kugel, S. Pohl, H. Naher, and H. J. Staehle. 2001. Combined mechanical and antibiotic periodontal therapy in a case of Papillon-Lefevre syndrome. J. Periodontol. 72:542-549.
21. Eley, B. M., and S. W. Cox. 2003. Proteolytic and hydrolytic enzymes from putative periodontal pathogens: characterization, molecular genetics, effects on host defenses and tissues and detection in gingival crevice fluid. Periodontology 2000. 31:105-124.
22. Eronat, N., F. Ucar, and G. Kilinc. 1993. Papillon Lefevre syndrome: treatment of two cases with a clinical microbiological and histopathological investigation. J. Clin. Pediatr. Dent. 17:99-104.
23. Firatli, E., N. Gurel, A. Efeoglu, and S. Badur. 1996. Clinical and immunological findings in 2 siblings with Papillon-Lefevre syndrome. J. Periodontol. 67:1210-1215.
24. Firatli, E., B. Tuzun, and A. Efeoglu. 1996. Papillon-Lefevre syndrome. Analysis of neutrophil chemotaxis. J. Periodontol. 67:617-620.
25. Frohm, M., B. Agerberth, G. Ahangari, M. Stahle-Backdahl, S. Liden, H. Wigzell, and G. H. Gudmundsson. 1997. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272:15258-15263.
26. Ghaffer, K. A., F. M. Zahran, H. M. Fahmy, and R. S. Brown. 1999. Papillon-Lefevre syndrome: neutrophil function in 15 cases from 4 families in Egypt. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodont. 88:320-325.
27. Gongora, R., A. Corell, J. R. Regueiro, M. Carasol, C. Rodriguez-Gallego, E. Paz-Artal, M. Timon, L. Allende, and A. Arnaiz-Villena. 1994. Peripheral blood reduction of memory (CD29+, CD45RO+, and "bright" CD2+ and LFA-1+) T lymphocytes in Papillon-Lefevre syndrome. Hum. Immunol. 41:185-192.
28. Hamers, M. N., A. A. Bot, R. S. Weening, H. J. Sips, and D. Roos. 1984. Kinetics and mechanism of the bactericidal action of human neutrophils against Escherichia coli. Blood 64:635-641.
29. Hart, T. C., P. S. Hart, D. W. Bowden, M. D. Michalec, S. A. Callison, S. J. Walker, Y. Zhang, and E. Firatli. 1999. Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome. J. Med. Genet. 36:881-887.
30. Haubek, D., J. M. Dirienzo, E. M. Tinoco, J. Westergaard, N. J. Lopez, C. P. Chung, K. Poulsen, and M. Kilian. 1997. Racial tropism of a highly toxic clone of Actinobacillus actinomycetemcomitans associated with juvenile periodontitis. J. Clin. Microbiol. 35:3037-3042.
31. Haubek, D., K. Poulsen, J. Westergaard, G. Dahlen, and M. Kilian. 1996. Highly toxic clone of Actinobacillus actinomycetemcomitans in geographically widespread cases of juvenile periodontitis in adolescents of African origin. J. Clin. Microbiol. 34:1576-1578.
32. Hodge, P., and B. Michalowicz. 2001. Genetic predisposition to periodontitis in children and young adults. Periodontol. 2000. 26:113-134.
33. Ishikawa, I., M. Umeda, and N. Laosrisin. 1994. Clinical, bacteriological, and immunological examinations and the treatment process of two Papillon-Lefevre syndrome patients. J. Periodontol. 65:364-371.
34. Johansson, A., R. Claesson, G. Belibasakis, E. Makoveichuk, L. Hanstrom, G. Olivecrona, G. Sandstrom, and S. Kalfas. 2001. Protease inhibitors, the responsible components for the serum-dependent enhancement of Actinobacillus actinomycetemcomitans leukotoxicity. Eur. J. Oral Sci. 109:335-341.
35. Johansson, A., R. Claesson, L. Hanstrom, G. Sandstrom, and S. Kalfas. 2000. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans. J. Periodontal Res. 35:85-92.
36. Johansson, A., L. Hanstrom, and S. Kalfas. 2000. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacteria from the subgingival flora. Oral Microbiol. Immunol. 15:218-225.
37. Johansson, A., G. Sandstrom, R. Claesson, L. Hanstrom, and S. Kalfas. 2000. Anaerobic neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to the bacterial leukotoxicity. Eur. J. Oral Sci. 108:136-146.
38. Kadowaki, T., A. Baba, N. Abe, R. Takii, M. Hashimoto, T. Tsukuba, S. Okazaki, Y. Suda, T. Asao, and K. Yamamoto. 2004. Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors. Mol. Pharmacol.
39. Kam, C. M., J. E. Kerrigan, K. M. Dolman, R. Goldschmeding, A. E. dem Borne, and J. C. Powers. 1992. Substrate and inhibitor studies on proteinase 3. FEBS Lett. 297:119-123.
40. Kelk, P., R. Claesson, L. Hanstrom, U. H. Lerner, S. Kalfas, and A. Johansson. 2005. Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect. Immun. 73:453-458.
41. Kleinfelder, J. W., H. H. Topoll, H. R. Preus, R. F. Muller, D. E. Lange, and W. Bocker. 1996. Microbiological and immunohistological findings in a patient with Papillon-Lefevre syndrome. J. Clin. Periodontol. 23:1032-1038.
42. Kressin, S., A. Herforth, S. Preis, V. Wahn, and H. G. Lenard. 1995. Papillon-Lefevre syndrome-successful treatment with a combination of retinoid and concurrent systematic periodontal therapy: case reports. Quintessence Int. 26:795-803.
43. Lally, E. T., I. R. Kieba, A. Sato, C. L. Green, J. Rosenbloom, J. Korostoff, J. F. Wang, B. J. Shenker, S. Ortlepp, M. K. Robinson, and P. C. Billings. 1997. RTX toxins recognize a beta2 integrin on the surface of human target cells. J. Biol. Chem. 272:30463-30469.
44. Lehrer, R. I., and T. Ganz. 1999. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 11:23-27.
45. Liu, R., C. Cao, H. Meng, and Z. Tang. 2000. Leukocyte functions in 2 cases of Papillon-Lefevre syndrome. J. Clin. Periodontol. 27:69-73.
46. Lundgren, T., S. Renvert, P. N. Papapanou, and G. Dahlen. 1998. Subgingival microbial profile of Papillon-Lefevre patients assessed by DNA-probes. J. Clin. Periodontol. 25:624-629.
47. Lyberg, T. 1982. Immunological and metabolical studies in two siblings with Papillon-Lefevre syndrome. J. Periodontal Res. 17:563-568.
48. MacIvor, D. M., S. D. Shapiro, C. T. Pham, A. Belaaouaj, S. N. Abraham, and T. J. Ley. 1999. Normal neutrophil function in cathepsin G-deficient mice. Blood 94:4282-4293.
49. Mandell, G. L. 1974. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect. Immun. 9:337-341.
50. Marsh, P. M. M. 1992. Oral microbiology. Chapman & Hall, New York, N.Y.
51. Miyasaki, K. T., M. E. Wilson, A. J. Brunetti, and R. J. Genco. 1986. Oxidative and nonoxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils. Infect. Immun. 53:154-160.
52. Ong, P. Y., T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R. L. Gallo, and D. Y. Leung. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347:1151-1160.
53. Petit, M. D., T. J. M. van Steenbergen, L. M. Scholte, U. van der Velden, and J. de Graaff. 1993. Epidemiology and transmission of Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans among children and their family members: a report of four surveys. J. Clin. Periodontol. 20:641-650.
54. Pham, C. T. N., J. L. Ivanovich, S. Z. Raptis, B. Zehnbauer, and T. J. Ley. 2004. Papillon-Lefevre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J. Immunol. 173:7277-7281.
55. Pratchyaprnit, W. O., and P. Kullavanijaya. 2002. Papillon-Lefevre syndrome: a case report. J. Dermatol. 29:329-335.
56. Putsep, K., G. Carlsson, H. G. Boman, and M. Andersson. 2002. Deficiency of antibacterial peptides in patients with Morbus Kostmann: an observation study. Lancet 360:1144-1149.
57. Reeves, E. P., H. Lu, H. L. Jacobs, C. G. Messina, S. Bolsover, G. Gabella, E. O. Potma, A. Warley, J. Roes, and A. W. Segal. 2002. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416:291-297.
58. Richardson, K. C., L. Jarett, and E. H. Finke. 1960. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol. 35:313-325.
59. Robertson, K. L., D. B. Drucker, J. James, A. S. Blinkhorn, S. Hamlet, and P. S. Bird. 2001. A microbiological study of Papillon-Lefevre syndrome in two patients. J. Clin. Pathol. 54:371-376.
60. Rudiger, S., G. Petersilka, and T. F. Flemmig. 1999. Combined systemic and local antimicrobial therapy of periodontal disease in Papillon-Lefevre syndrome: a report of 4 cases. J. Clin. Periodontol. 26:847-854.
61. Salyers, A. and White, A. 1994. Bacterial Pathogenesis: a molecular approach. ASM Press, Washington, D.C.
62. Schroeder, H. E., R. A. Seger, H. U. Keller, and E. M. Rateitschak-Pluss. 1983. Behavior of neutrophilic granulocytes in a case of Papillon-Lefevre syndrome. J. Clin. Periodontol. 10:618-635.
63. Slots, J., and M. Ting. 1999. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol. 2000 20:82-121.
64. Smeianov, V., K. Scott, and G. Reid. 2000. Activity of cecropin P1 and FA-LL-37 against urogenital microflora. Microbes Infect. 2:773-777.
65. Sorensen, O. E., P. Follin, A. H. Johnsen, J. Calafat, G. S. Tjabringa, P. S. Hiemstra, and N. Borregaard. 2001. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97:3951-3959.
66. Sorensen, O. E., L. Gram, A. H. Johnsen, E. Andersson, S. Bangsboll, G. S. Tjabringa, P. S. Hiemstra, J. Malm, A. Egesten, and N. Borregaard. 2003. Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J. Biol. Chem. 278:28540-28546.
67. Stabholz, A., N. S. Taichman, and W. A. Soskolne. 1995. Occurrence of Actinobacillus actinomycetemcomitans and anti-leukotoxin antibodies in some members of an extended family affected by Papillon-Lefevre syndrome. J. Periodontol. 66:653-657.
68. Stalder, J. F., T. P. Huu, B. Dreno, A. Vergracht, J. D. Bignon, and P. Litoux. 1989. Defective leucocyte adhesion in Papillon-Lefevre syndrome. Br. J. Dermatol. 121:668-669.
69. Tanaka, D., K. T. Miyasaki, and R. I. Lehrer. 2000. Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. Oral Microbiol. Immunol. 15:226-231.
70. Tinanoff, N., J. M. Tanzer, K. S. Kornman, and E. G. Maderazo. 1986. Treatment of the periodontal component of Papillon-Lefevre syndrome. J. Clin. Periodontol. 13:6-10.
71. Tinanoff, N., P. Tempro, and E. G. Maderazo. 1995. Dental treatment of Papillon-Lefevre syndrome: 15-year follow-up. J. Clin. Periodontol. 22:609-612.
72. Toomes, C., J. James, A. J. Wood, C. L. Wu, D. McCormick, N. Lench, C. Hewitt, L. Moynihan, E. Roberts, C. G. Woods, A. Markham, M. Wong, R. Widmer, K. A. Ghaffar, M. Pemberton, I. R. Hussein, S. A. Temtamy, R. Davies, A. P. Read, P. Sloan, M. J. Dixon, and N. S. Thakker. 1999. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat. Genet. 23:421-424.
73. Ullbro, C., C. G. Crossner, T. Lundgren, P. A. Stalblad, and S. Renvert. 2000. Osseointegrated implants in a patient with Papillon-Lefevre syndrome: a 4 1/2-year follow up. J. Clin. Periodontol. 27:951-954.
74. Van Dyke, T. E., M. A. Taubman, J. L. Ebersole, A. D. Haffajee, S. S. Socransky, D. J. Smith, and R. J. Genco. 1984. The Papillon-Lefevre syndrome: neutrophil dysfunction with severe periodontal disease. Clin. Immunol. Immunopathol. 31:419-429.
75. Velazco, C. H., C. Coelho, F. Salazar, A. Contreras, J. Slots, and J. J. Pacheco. 1999. Microbiological features of Papillon-Lefevre syndrome periodontitis. J. Clin. Periodontol. 26:622-627.
76. Wara-aswapati, N., J. Lertsirivorakul, T. Nagasawa, Y. Kawashima, and I. Ishikawa. 2001. Papillon-Lefevre syndrome: serum immunoglobulin G (IgG) subclass antibody response to periodontopathic bacteria. A case report. J. Periodontol. 72:1747-1754.
77. Welch, R. A. 1991. Pore-forming cytolysins of gram-negative bacteria. Mol. Microbiol. 5:521-528.
78. Zanetti, M., R. Gennaro, and D. Romeo. 1995. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374:1-5.